Skip to content

Released Mar 27, 2014, after the close

10-K filed Mar 27, 2014, 86 days after period end · 0001144204-14-018406

Q4 2013 · 10-K
Revenue$9.60M+5.8% vs Q4 2012+61.4% vs Q3 2013
Net Income$597.00K+31.8% vs Q4 2012−51.7% vs Q3 2013
EPS Diluted$0.04±0.0% vs Q4 2012−50.0% vs Q3 2013
Gross Profit$6,587,000+15.8%
Operating Incomederived$602,000+33.5%
Operating Cash Flowderived$856,000N/M
Free Cash Flowderived$738,000N/M
Margins · derived
Gross margin68.6%+6.0 pt vs Q4 2012
Operating margin6.3%+1.3 pt vs Q4 2012
Net margin6.2%+1.2 pt vs Q4 2012

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2013Q4 2012Q4 2011derived from reported figuresQ4 2010derived from reported figures
Revenue$9.60M$9.08M$7.46M—
Net Income$597.00K$453.00K-$1.83M—
EPS Diluted$0.04$0.04——

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR